{"id":37092,"date":"2021-06-29T17:43:57","date_gmt":"2021-06-30T00:43:57","guid":{"rendered":"https:\/\/lapost.us\/?p=37092"},"modified":"2021-06-29T17:43:57","modified_gmt":"2021-06-30T00:43:57","slug":"sanofi-places-bet-on-mrna-vaccines-with-investment","status":"publish","type":"post","link":"https:\/\/lapost.us\/?p=37092","title":{"rendered":"Sanofi places bet on mRNA vaccines with investment"},"content":{"rendered":"<p>The French drugmaker Sanofi says it plans to invest hundreds of millions of dollars annually to research mRNA vaccines after some COVID-19 vaccines have successfully utilized the technology.<\/p>\n<p>The company\u00a0<a href=\"https:\/\/click1.email.thehill.com\/bqfbvsdkzppynsnpyjgzzybbzdympdpttqzkscmplpzzzz_essrbbysyfrhsbddbttr.html?a=&amp;b=40330\" target=\"_blank\" rel=\"noopener\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/click1.email.thehill.com\/bqfbvsdkzppynsnpyjgzzybbzdympdpttqzkscmplpzzzz_essrbbysyfrhsbddbttr.html?a%3D%26b%3D40330&amp;source=gmail&amp;ust=1625091915897000&amp;usg=AFQjCNGm2ZjyEjDe_7WIHJg2KZTkH45FKA\">announced Tuesday<\/a>\u00a0that it will direct 400 million euros, or $477 million, every year to a Center of Excellence designed to speed up the research and development of mRNA vaccines.<\/p>\n<p>The effort would aim to expand usage of mRNA vaccine technology beyond COVID-19 shots \u201cto routine use in diseases with high unmet need.\u201d The drugmaker predicts it will have at least six next-generation candidate vaccines by 2025.<\/p>\n<p>\u201cWhile mRNA won\u2019t be the solution for every infectious disease, its translation into routine prevention could have immense impact for many unmet public health needs,\u201d Thomas Triomphe, the global head of Sanofi Pasteur, said in a release.<\/p>\n<p><strong>Why this matters:<\/strong>\u00a0As one of the largest vaccine manufacturers worldwide, Sanofi\u2019s investment in mRNA vaccine research and development signals how mRNA technology could transform the vaccine industry.<\/p>\n<p>Two of the three vaccines authorized in the U.S. \u2014 the Pfizer-BioNTech and Moderna vaccines \u2014 use mRNA technology and are considered to be effective against COVID-19 and the current variants.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The French drugmaker Sanofi says it&#46;&#46;&#46;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,16],"tags":[],"class_list":["post-37092","post","type-post","status-publish","format-standard","hentry","category-business","category-health"],"_links":{"self":[{"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts\/37092","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=37092"}],"version-history":[{"count":1,"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts\/37092\/revisions"}],"predecessor-version":[{"id":37093,"href":"https:\/\/lapost.us\/index.php?rest_route=\/wp\/v2\/posts\/37092\/revisions\/37093"}],"wp:attachment":[{"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=37092"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=37092"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lapost.us\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=37092"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}